NASDAQ:THMO

ThermoGenesis (THMO) Stock Price, News & Analysis

ThermoGenesis logo

About ThermoGenesis Stock (NASDAQ:THMO)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
12 shs
Average Volume
1,148 shs
Market Capitalization
$1 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ThermoGenesis Holdings, Inc. develops automated technologies for processing and preserving cells used in regenerative medicine and cell-based therapies. Its systems are designed to support the preparation, handling and storage of biological materials for clinical and commercial applications.

The company’s products have included the AXP system for processing cord blood, the BioArchive system for automated cryogenic storage, and the CAR-TXpress platform, which supports cell separation and processing for cell therapy manufacturing.

ThermoGenesis traces its roots to ThermoGenesis Corporation and has focused on cell-processing technology as the therapeutic landscape has evolved. Its products have been intended for use by hospitals, laboratories, cell banks and developers of cell-based therapies.

AI Generated. May Contain Errors.

Receive THMO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ThermoGenesis and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

THMO Stock News Headlines

ThermoGenesis Holdings Inc.
$0. Later: $29.97.
Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that link expires, it returns to its usual price of $29.97. The content stays the same - plain-English lessons and a handful of proven techniques - only the price changes. Waiting means paying for something you could have gotten for free.tc pixel
North American Morning Briefing: Stock Futures, -2-
See More Headlines

THMO Stock Analysis - Frequently Asked Questions

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) released its earnings results on Friday, November, 12th. The company reported ($6.75) earnings per share for the quarter, missing analysts' consensus estimates of ($3.60) by $3.15. The firm had revenue of $3.16 million for the quarter, compared to analysts' expectations of $3.06 million.

ThermoGenesis shares reverse split before market open on Friday, December 23rd 2022.The 1-45 reverse split was announced on Friday, December 23rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, December 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that ThermoGenesis investors own include Bionano Genomics (BNGO), Tonix Pharmaceuticals (TNXP), Teladoc Health (TDOC), Co-Diagnostics (CODX), Jaguar Animal Health (JAGX), OPKO Health (OPK) and Plug Power (PLUG).

Company Calendar

Today
11/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Laboratory apparatus & furniture
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:THMO
CIK
811212
Employees
25
Year Founded
1986

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$9.61 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.99) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
7,953,000
Free Float
1,750,000
Market Cap
$1 thousand
Optionable
Not Optionable
Beta
1.05

Social Links

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NASDAQ:THMO) was last updated on 11/10/2026 by MarketBeat.com Staff.
From Our Partners